As of 2025-09-18, the Relative Valuation of Heron Therapeutics Inc (HRTX) is (0.11) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.21 USD, the upside of Heron Therapeutics Inc based on Relative Valuation is -108.7%.
The range of the Relative Valuation is (0.08) - (0.12) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 22.3x | 18.1x |
| Forward P/E multiples | 13.8x - 19.4x | 16.6x |
| Fair Price | (0.08) - (0.12) | (0.11) |
| Upside | -107.0% - -109.7% | -108.7% |
| Date | P/E |
| 2025-09-12 | -207.46 |
| 2025-09-11 | -210.75 |
| 2025-09-10 | -209.11 |
| 2025-09-09 | -214.05 |
| 2025-09-08 | -214.05 |
| 2025-09-05 | -215.69 |
| 2025-09-04 | -217.34 |
| 2025-09-03 | -218.99 |
| 2025-09-02 | -217.34 |
| 2025-08-29 | -222.28 |
| 2025-08-28 | -228.86 |
| 2025-08-27 | -223.93 |
| 2025-08-26 | -232.16 |
| 2025-08-25 | -227.22 |
| 2025-08-22 | -230.51 |
| 2025-08-21 | -217.34 |
| 2025-08-20 | -214.05 |
| 2025-08-19 | -212.40 |
| 2025-08-18 | -214.05 |
| 2025-08-15 | -218.99 |
| 2025-08-14 | -222.28 |
| 2025-08-13 | -230.51 |
| 2025-08-12 | -215.69 |
| 2025-08-11 | -210.75 |
| 2025-08-08 | -217.34 |
| 2025-08-07 | -302.96 |
| 2025-08-06 | -298.02 |
| 2025-08-05 | -298.02 |
| 2025-08-04 | -288.14 |
| 2025-08-01 | -278.26 |
| 2025-07-31 | -284.85 |
| 2025-07-30 | -294.73 |
| 2025-07-29 | -304.60 |
| 2025-07-28 | -306.25 |
| 2025-07-25 | -314.48 |
| 2025-07-24 | -312.84 |
| 2025-07-23 | -322.72 |
| 2025-07-22 | -312.84 |
| 2025-07-21 | -316.13 |
| 2025-07-18 | -317.78 |
| 2025-07-17 | -329.30 |
| 2025-07-16 | -332.59 |
| 2025-07-15 | -335.89 |
| 2025-07-14 | -349.06 |
| 2025-07-11 | -358.94 |
| 2025-07-10 | -365.53 |
| 2025-07-09 | -367.17 |
| 2025-07-08 | -362.23 |
| 2025-07-07 | -354.00 |
| 2025-07-03 | -362.23 |